ICD-10-CM Billable Code

R85.3

Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code R85.3 refers to the detection of abnormal levels of substances, primarily nonmedicinal, in specimens collected from the digestive organs and abdominal cavity. This code is used by healthcare professionals to classify and document findings where the composition of digestive fluids or tissues shows deviations from normal, which could be indicative of various health conditions. Recognizing these abnormal substance levels can be a crucial step in diagnosing and managing gastrointestinal and abdominal disorders.

Causes & Symptoms

Clinical Causes: Infections of the digestive tract that alter the chemical composition of fluids Inflammatory conditions like gastritis or pancreatitis Presence of abnormal or malignant growths affecting the digestive organs Digestive enzyme imbalances or malabsorption syndromes Chemical or toxin exposure affecting abdominal organs Structural abnormalities leading to altered secretions Liver or gallbladder diseases impacting digestive chemistry Metabolic disorders influencing the breakdown or absorption of substances

Key Symptoms: Unexplained abdominal pain or discomfort Digestive disturbances such as nausea, vomiting, or diarrhea Unusual tastes or foul odors in the mouth Unplanned weight changes Changes in bowel habits, including constipation or diarrhea Signs of gastrointestinal bleeding like blood in stool or vomit Persistent bloating or feeling of fullness Jaundice or yellowing of the skin and eyes if liver involvement is suspected

Diagnostic & Treatment

Diagnosis Path: To identify abnormal substance levels in specimens from the digestive organs, healthcare providers may recommend various diagnostic procedures. These can include endoscopic examinations, where tools are used to visually inspect the digestive tract and obtain tissue or fluid samples. Laboratory analysis of collected samples helps determine the chemical composition and detect any irregular substances. Additional tests, such as imaging studies like ultrasounds or CT scans, may be utilized to identify underlying structural or pathological causes that could contribute to abnormal findings.

Treatment Protocols: Management of abnormal substance levels depends on the underlying cause. Approaches may include dietary modifications, medications to reduce inflammation, or treatments targeted at specific infections or conditions. In cases involving structural abnormalities or tumors, surgical intervention might be necessary. Supportive therapies to restore normal digestive function or to address metabolic imbalances can also be part of the treatment plan. Regular monitoring and follow-up testing are typically advised to assess response to therapy and ensure ongoing gastrointestinal health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is R85.3 a billable ICD-10 code?
Yes, R85.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report R85.3?
Clinical documentation must specify the nature of Abnormal level of substances chiefly nonmedicinal as to source in specimens from digestive organs and abdominal cavity and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

abdominal chiefly substances cavity organs level abnormal nonmedicinal source digestive specimens